YILDIRIM, H. Ç. Et Al. 2024. Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab. BIOMOLECULES AND BIOMEDICINE , vol.24, no.4 , 998-1003.

YILDIRIM, H. Ç., Anik, H., ATEŞ ÖZDEMİR, D., Ismayilov, R., AKYILDIZ, A., ÇAYIRÖZ, K., ... Ceyhan, F.(2024). Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab. BIOMOLECULES AND BIOMEDICINE , vol.24, no.4, 998-1003.

YILDIRIM, HASAN Et Al. "Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab," BIOMOLECULES AND BIOMEDICINE , vol.24, no.4, 998-1003, 2024

YILDIRIM, HASAN Ç. Et Al. "Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab." BIOMOLECULES AND BIOMEDICINE , vol.24, no.4, pp.998-1003, 2024

YILDIRIM, H. Ç. Et Al. (2024) . "Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab." BIOMOLECULES AND BIOMEDICINE , vol.24, no.4, pp.998-1003.

@article{article, author={HASAN ÇAĞRI YILDIRIM Et Al. }, title={Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab}, journal={BIOMOLECULES AND BIOMEDICINE}, year=2024, pages={998-1003} }